About Us

GelMEDIX Inc. is an early-stage ocular cell therapy company committed to improving current approaches by engineering formulations to improve cell viability, engraftment, and tissue regeneration with the aim of restoring vision. 

​

GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA).